Pharmafile Logo

dual tasking

The Future of Wearable and Implantable Devices

Nance Dicciani & Denise Devine, Co-founders of RTM Vital Signs, join Natalie Yeadon, Co-Founder & CEO at Impetus Digital. We explore continuous ambulatory vital sign monitoring using wearable and implantable devices....

Impetus Digital

Designing Ethical AI and Healthcare Technologies

Bryn Williams-Jones, Professor & Director of the Bioethics Program at ESPUM and Editor-in-Chief of the Canadian Journal of Bioethics discusses the bioethical challenges of innovative healthcare technologies such as AI, digital therapeutics,...

Impetus Digital

https://youtu.be/5jUf-4v_g7w

Attacking COVID-19 from All Angles

Michael Taylor, CEO & Founder of Environmental Surface Solutions, explores alternative and supplementary approaches to fighting COVID-19 and other pathogens. In particular, we focus on environmental solutions for not only eradicating...

Impetus Digital

- PMLiVE

Questions surrounding remdesivir treatment for COVID-19 are ‘complicated’, says NEJM

Editorial highlights issues with WHO’s Solidarity trial

Bayer symbol

Bayer strengthens cell and gene therapy focus with new platform

Platform builds on previous acquisition deals for AskBio and BlueRock

- PMLiVE

Not waving but drowning. Reflections on data curation in the age of information overload

As of October 2019 there were over 300,000 clinical studies registered worldwide, compared to just over 2,100 in the year 2000’It’s common to hear colleagues and friends bemoan the huge...

Porterhouse Medical Group

- PMLiVE

US secures 650,000 additional doses of Lilly’s COVID-19 antibody

This takes the total purchased amount to 950,000 doses

- PMLiVE

WHO set to review Pfizer/BioNTech COVID-19 vaccine for emergency use listing

Follows approval for emergency use in the UK yesterday

- PMLiVE

Sanofi Genzyme takes home New Product Introductions Award at PMEA 2020

Winning entry stood out in a strong category

- PMLiVE

Launch leaders’ blog part 3

How can launch leaders innovate?

- PMLiVE

EMA launches rolling review of J&J’s COVID-19 vaccine

Vaccine entered phase 3 testing in September

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links